Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer.

Nam KH, Lee BL, Park JH, Kim J, Han N, Lee HE, Kim MA, Lee HS, Kim WH.

Pathobiology. 2013;80(2):87-94. doi: 10.1159/000341685. Epub 2012 Oct 3.

PMID:
23038627
2.

MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.

Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y.

J Cancer Res Clin Oncol. 2006 Dec;132(12):817-23. Epub 2006 Jun 29.

PMID:
16807756
3.

The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.

Li XH, Zheng HC, Wang ZG, Takahashi H, Yang XH, Guan YF, Takano Y.

Anticancer Res. 2008 Mar-Apr;28(2A):1061-7.

4.

Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer.

Park JH, Lee BL, Yoon J, Kim J, Kim MA, Yang HK, Kim WH.

Hum Pathol. 2010 Dec;41(12):1664-73. doi: 10.1016/j.humpath.2010.06.004. Epub 2010 Sep 24.

PMID:
20869748
5.

Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.

Ide M, Kato T, Ogata K, Mochiki E, Kuwano H, Oyama T.

Ann Surg Oncol. 2012 Oct;19(11):3506-14. doi: 10.1245/s10434-012-2437-9. Epub 2012 Jun 14.

PMID:
22695933
6.

The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.

Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y.

Oncol Rep. 2007 Sep;18(3):601-9.

PMID:
17671707
7.

[Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].

Gao X, Sun Y, Huang L, Chen XY, Zhang KL, Kong QY, Liu J, Li H.

Ai Zheng. 2005 Mar;24(3):311-6. Chinese.

PMID:
15757532
8.

Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.

Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM.

Hepatogastroenterology. 1997 Mar-Apr;44(14):604-9.

PMID:
9164544
9.

Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.

He WL, Li YH, Yang DJ, Song W, Chen XL, Liu FK, Wang Z, Li W, Chen W, Chen CY, He YL, Zhan WH.

Eur J Surg Oncol. 2013 Feb;39(2):141-9. doi: 10.1016/j.ejso.2012.08.023. Epub 2012 Sep 19.

PMID:
22999412
10.

Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.

Woo S, Lee BL, Yoon J, Cho SJ, Baik TK, Chang MS, Lee HE, Park JW, Kim YH, Kim WH.

Pathobiology. 2011;78(6):295-301. doi: 10.1159/000321696. Epub 2011 Nov 18.

PMID:
22104200
11.

Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.

Ru GQ, Wang HJ, Xu WJ, Zhao ZS.

Pathol Oncol Res. 2011 Jun;17(2):341-7. doi: 10.1007/s12253-010-9332-0. Epub 2010 Nov 23.

PMID:
21104359
12.

Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.

Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He WL, Xu JB, Zan WH.

J Surg Oncol. 2012 Sep 1;106(3):304-10. doi: 10.1002/jso.23008. Epub 2012 Jan 9.

PMID:
22231933
13.

Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.

Lee BL, Lee HS, Jung J, Cho SJ, Chung HY, Kim WH, Jin YW, Kim CS, Nam SY.

Clin Cancer Res. 2005 Apr 1;11(7):2518-25.

14.

Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.

PMID:
23334926
15.

Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma.

Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T, Yano M, Nakamori S, Sakon M, Monden M, Aozasa K.

J Clin Oncol. 2003 Jul 1;21(13):2537-44.

PMID:
12829673
16.

Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas.

Chen YB, Hou JH, Feng XY, Chen S, Zhou ZW, Zhang XS, Cai MY.

J Surg Oncol. 2012 May;105(6):542-7. doi: 10.1002/jso.22151. Epub 2011 Nov 17.

PMID:
22095667
17.

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

Begnami MD, Fukuda E, Fregnani JH, Nonogaki S, Montagnini AL, da Costa WL Jr, Soares FA.

J Clin Oncol. 2011 Aug 1;29(22):3030-6. doi: 10.1200/JCO.2010.33.6313. Epub 2011 Jun 27.

18.

SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.

Liu Y, Luo X, Deng J, Pan Y, Zhang L, Liang H.

Tumour Biol. 2015 Apr;36(4):2685-94. doi: 10.1007/s13277-014-2891-z. Epub 2014 Dec 4.

PMID:
25472580
19.

WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells.

Yuan G, Regel I, Lian F, Friedrich T, Hitkova I, Hofheinz RD, Ströbel P, Langer R, Keller G, Röcken C, Zimmermann W, Schmid RM, Ebert MP, Burgermeister E.

Oncogene. 2013 Jan 17;32(3):375-87. doi: 10.1038/onc.2012.40. Epub 2012 Feb 27.

PMID:
22370641
20.

Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.

Zheng HC, Xu XY, Xia P, Yu M, Takahashi H, Takano Y.

Hum Pathol. 2010 Sep;41(9):1255-64. doi: 10.1016/j.humpath.2010.02.003. Epub 2010 May 5.

PMID:
20447678
Items per page

Supplemental Content

Write to the Help Desk